top of page

RESEARCH
NOTES

Caligan Partners LP: Activist Profile

Founded in 2017, Caligan Partners is a prominent specialty hedge fund based in New York, led by David Johnson. The fund specializes in long-biased activist equity strategies and occasionally invests in distressed debt and high absolute return opportunities.


Caligan Partners primarily focuses on investment opportunities in the healthcare sector, with its holdings currently concentrated entirely in this industry, accounting for 100% of its portfolio value. The firm engages in both long and short positions, targeting equity opportunities in publicly traded healthcare companies.


David Johnson

David Johnson, Partner and Co-Founder of Caligan Partners LP, previously served as a Managing Director at The Carlyle Group (2010–2017) and Vice President in Principal Investments at Morgan Stanley (2004–2010). He was a director at AMAG Pharmaceuticals (2019–2020) and serves on the boards of the Children's Scholarship Fund and the Harvard College Fund. He holds an A.B. in Applied Mathematics, cum laude, and an S.M. in Applied Mathematics from Harvard College (2004).


Letters & Presentations

KNOWLES CORP 29-Mar-2019 Letter

AMAG PHARMACEUTICALS, INC. 16-Sep-2019 Letter

AMAG PHARMACEUTICALS, INC. 26-Sep-2019 Letter

ANIKA THERAPEUTICS, INC. 21-Feb-2023 Letter

KNOWLES CORP 3-Apr-2019 Presentation

KNOWLES CORP 18-Apr-2019 Presentation

AMAG PHARMACEUTICALS, INC. 4-Sep-2019 Presentation


Active 13D Positions

Stock

Company name

Sector

% of Portfolio

Link

ANIK

Anika Therapeutics Inc

HEALTH CARE

11.2%

EXEL

Exelixis Inc

HEALTH CARE

12.6%


1 view0 comments

Recent Posts

See All

Comments


Insight

Insight

Monthly reports

Activism

Research

Research

Subscribe to our newsletter • Don’t miss out!

Anchor 1
Flag on Mountain Peak

Address

Contact

March Intelligence Research LLP,

65, Sakthi Garden, 2nd cross street, Okkiam thoraipakkam, Chennai, Tamilnadu, India

Raghuraman, Founder,  Linkedin

001-9790937345

raghu@snowballresearch.com

snowball research

Value investing  | Qualitative screening

bottom of page